Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOCONEXENT\ICOSAPENT\OMEGA-3 FATTY ACIDS for Hypertriglyceridaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where DOCONEXENT\ICOSAPENT\OMEGA-3 FATTY ACIDS was used for Hypertriglyceridaemia.

Most Reported Side Effects for DOCONEXENT\ICOSAPENT\OMEGA-3 FATTY ACIDS

Side Effect Reports % Deaths Hosp.
Asthma 15 22.4% 1 12
Dyspnoea 15 22.4% 1 12
Coronary artery disease 14 20.9% 0 14
Therapeutic product effect incomplete 14 20.9% 0 11
Wheezing 13 19.4% 1 10
Infection 12 17.9% 0 9
Productive cough 12 17.9% 0 9
Sleep disorder due to a general medical condition 12 17.9% 0 9
Drug ineffective 10 14.9% 5 10
Loss of personal independence in daily activities 10 14.9% 0 7
Acute myocardial infarction 9 13.4% 0 9
Addison's disease 9 13.4% 0 6
Drug-induced liver injury 9 13.4% 0 9
Hepatic cirrhosis 9 13.4% 0 9
Myocardial infarction 9 13.4% 0 9

Other Indications for DOCONEXENT\ICOSAPENT\OMEGA-3 FATTY ACIDS

Product used for unknown indication (45)

Other Drugs Used for Hypertriglyceridaemia

FENOFIBRATE (517) ATORVASTATIN (117) OMEGA-3-CARBOXYLIC ACIDS (116) GEMFIBROZIL (112) ICOSAPENT ETHYL (98) EVOLOCUMAB (70) OMEGA-3-ACID ETHYL ESTERS (58) ROSUVASTATIN (54) ALIROCUMAB (51) OMEGA-3 FATTY ACIDS (43)

Related Pages

DOCONEXENT\ICOSAPENT\OMEGA-3 FATTY ACIDS Full Profile All Hypertriglyceridaemia Drugs DOCONEXENT\ICOSAPENT\OMEGA-3 FATTY ACIDS Demographics DOCONEXENT\ICOSAPENT\OMEGA-3 FATTY ACIDS Timeline